Literature DB >> 16253075

Effects of enalaprilat on the renin-angiotensin-aldosterone system and on renal function during CO2 pneumoperitoneum.

Marcelo Rodrigues Borba1, Roberto Iglesias Lopes, Murilo Carmona, Boulangier Mioto Neto, Sérgio Carlos Nahas, Paulo Roberto Bueno Pereira.   

Abstract

BACKGROUND AND
PURPOSE: Mechanical and hormonal factors have been implicated in pneumoperitoneum-induced renal alterations. The aim of this study was to evaluate the effects of enalaprilat (Vasotec) administration on renal function during CO2 pneumoperitoneum, given that this drug, which is an angiotensin-converting enzyme inhibitor, by inhibiting the renin-angiotensin-aldosterone system, alters hormone-induced changes during pneumoperitoneum.
MATERIALS AND METHODS: Thirty adult dogs were randomly assigned to one of three groups (N = 10 each): group A (pneumoperitoneum not performed); group B (CO2 + enalaprilat); group C CO2 only. The groups were analyzed with consideration for body weight, hematologic values, hemodynamic parameters, and renal function (plasma renin activity, urinary debt, creatinine clearance, and sodium-excretory fraction).
RESULTS: Hemodynamic and acid-basic parameter differences did not influence renal function. Plasma renin activity decreased significantly in group B compared with group C and stayed close to the values in group A. Creatinine clearance remained constant in group B, while in group C, creatinine clearance dropped, and this difference was statistically significant. Urinary debt and sodium-excretory fraction increased in group B during pneumoperitoneum and 60 minutes after this period in comparison with the other groups without reaching statistical significance.
CONCLUSION: The decline in urinary debt and in creatinine clearance observed during pneumoperitoneum was less accentuated with administration of enalaprilat.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16253075     DOI: 10.1089/end.2005.19.1026

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  4 in total

1.  Nitric oxide synthase inhibition aggravates the adverse renal effects of high but not low intraabdominal pressure.

Authors:  Bishara Bishara; Rawi Ramadan; Tony Karram; Hoda Awad; Niroz Abu-Saleh; Joseph Winaver; Akram Assadi; Zaid Abassi
Journal:  Surg Endosc       Date:  2009-08-26       Impact factor: 4.584

2.  Acute obstructive jaundice and chronic cirrhosis protect against the adverse renal effects of pneumoperitoneum: role of nitric oxide.

Authors:  Mohammad Naffaa; Niroz Abu-Saleh; Hoda Awad; Iyad Khamaysi; Tony Karram; Zaher S Azzam; Zaid Abassi; Bishara Bishara
Journal:  Surg Endosc       Date:  2013-01-26       Impact factor: 4.584

3.  Impact of pneumoperitoneum on renal perfusion and excretory function: beneficial effects of nitroglycerine.

Authors:  Bishara Bishara; Tony Karram; Samer Khatib; Rawi Ramadan; Henry Schwartz; Aaron Hoffman; Zaid Abassi
Journal:  Surg Endosc       Date:  2008-03-25       Impact factor: 4.584

4.  Renal Perfusion and Function during Pneumoperitoneum: A Systematic Review and Meta-Analysis of Animal Studies.

Authors:  Kimberley E Wever; Moira H D Bruintjes; Michiel C Warlé; Carlijn R Hooijmans
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.